Health & Fitness
Health and Fitness
Health and Fitness
Tue, May 7, 2013
[ Tue, May 07th 2013
] - Market Wire
[ Tue, May 07th 2013
] - Market Wire
[ Tue, May 07th 2013
] - Market Wire
[ Tue, May 07th 2013
] - Market Wire
[ Tue, May 07th 2013
] - Market Wire
[ Tue, May 07th 2013
] - Market Wire
[ Tue, May 07th 2013
] - Market Wire
[ Tue, May 07th 2013
] - Market Wire
[ Tue, May 07th 2013
] - Market Wire
[ Tue, May 07th 2013
] - Market Wire
[ Tue, May 07th 2013
] - Market Wire
[ Tue, May 07th 2013
] - Market Wire
[ Tue, May 07th 2013
] - Market Wire
[ Tue, May 07th 2013
] - Market Wire
[ Tue, May 07th 2013
] - Market Wire
Mon, May 6, 2013
[ Mon, May 06th 2013
] - Market Wire
[ Mon, May 06th 2013
] - Market Wire
[ Mon, May 06th 2013
] - Market Wire
[ Mon, May 06th 2013
] - Market Wire
[ Mon, May 06th 2013
] - Market Wire
[ Mon, May 06th 2013
] - Market Wire
[ Mon, May 06th 2013
] - Market Wire
[ Mon, May 06th 2013
] - Market Wire
Highline Research Advisors initiates coverage on Trovagene (NASDAQ:TROV) with a buy rating.
Highline Research Advisors initiates coverage on Trovagene (NASDAQ:TROV) with a buy rating. -- NEW YORK, May 6, 2013 /PRNewswire/ --
NEW YORK, May 6, 2013 /PRNewswire/ -- Today Highline Research Advisors initiated coverage through Empire Asset Management Company, a FINRA member (143007) of Trovagene (NASDAQ: [ TROV ]) with a BUY rating and 12 month price target of $17.00
SOURCE Empire Asset Management Company
Contributing Sources
